The company and its existing shareholders had previously downsized the offering to 17 million shares, down from an original target of 24 million. By the time the deal priced, the firm had raised $297.5 million, with Lyntris itself selling 5.7 million shares while existing investors scaled back their participation by more than 7.8 million shares.

While the broader U.S. IPO landscape has shown signs of a rebound in recent months, Lyntris’ performance highlights a trend of selective appetite among institutional buyers. This caution has forced a growing list of companies to trim deal sizes or lower price expectations, suggesting that even in a recovering market, investors are demanding greater concessions before backing new public ventures.